<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02534545</url>
  </required_header>
  <id_info>
    <org_study_id>RICA</org_study_id>
    <nct_id>NCT02534545</nct_id>
  </id_info>
  <brief_title>Remote Ischemic Conditioning for Avoiding Recurrence of Symptomatic Intracranial Atherosclerotic Stenosis (sICAS)</brief_title>
  <official_title>Remote Ischemic Conditioning for Avoiding Recurrence of Ischemic Stroke in Patients With Symptomatic Intracranial Atherosclerotic Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ji Xunming,MD,PhD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study will be to determine whether remote limb ischemic
      conditioning (RLIC) compared with sham RLIC (placebo) treatment reduces the 12-month risk of
      recurrent IS in patients with a recent TIA or IS caused by stenosis of a major intracranial
      artery.

      After screening period, eligible patients will be randomly allocated into 2 groups. In
      addition, all participants receive an usual clinical therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, Patients in the RLIC group will be treated with Renqiao Remote Ischemic
      Conditioning Device (Doctormate®) (200mmHg) once daily for 12 months; patients in the sham
      RLIC group will be treated with the Renqiao Remote Ischemic Conditioning Device (Doctormate®)
      (60mmHg) once daily for 12 months. In the study, the RLIC treatment will be comprised of 5
      cycles of bilateral upper limb ischemia and reperfusion, which will be induced by 2 cuffs
      placed around the upper arms respectively and inflated to 200mmHg for 5 minutes followed by 5
      minutes of reperfusion by cuff deflation. Sham RLIC treatment will be conducted using the
      same procedure but with a minimal inflation pressure of 60mmHg, which does not result in
      upper limb ischemia. In addition, all participants will have received their usual drug
      therapy according to local medical practice.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2015</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The time from randomization to the first occurrence of fatal or non-fatal ischemic stroke.</measure>
    <time_frame>During the first 12 months from randomization.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The time from randomization to the first occurrence of a composite of fatal or non-fatal stroke (ischemic and hemorrhagic), fatal or non-fatal myocardial infarction, and transient ischemic attack (TIA) .</measure>
    <time_frame>During the first 12 months from randomization.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time from randomization to the first occurrence of each component of the composite of fatal or non-fatal stroke (ischemic and hemorrhagic), fatal or non-fatal myocardial infarction, and TIA.</measure>
    <time_frame>During the first 12 months from randomization.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to death from all causes from randomization.</measure>
    <time_frame>During the first 12 months from randomization.</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Scores assessed by National Institutes of Health Stroke Scale(NIHSS)</measure>
    <time_frame>During the first 12 months from randomization.</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Scores assessed by modified Rankin Scale(mRS)</measure>
    <time_frame>During the first 12 months from randomization.</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Scores assessed by Barthel Index(BI).</measure>
    <time_frame>During the first 12 months from randomization.</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Number of participants with abnormal laboratory values</measure>
    <time_frame>3 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Number of participants with adverse events that are related to treatment</measure>
    <time_frame>3 years</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Intracranial Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Doctormate® (200mmHg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be treated with Renqiao Remote Ischemic Conditioning Device (Doctormate®) (200mmHg) once daily for 12 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Doctormate® (60mmHg)</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients will be treated with the Renqiao Remote Ischemic Conditioning Device (Doctormate®) (60mmHg) once daily for 12 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Doctormate® (200mmHg)</intervention_name>
    <description>Limb ischemia was induced by Renqiao Remote Ischemic Conditioning Device (Doctormate®) inflating tourniquets to 200mmHg.</description>
    <arm_group_label>Doctormate® (200mmHg)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Doctormate® (60mmHg)</intervention_name>
    <description>Limb ischemia was induced by Renqiao Remote Ischemic Conditioning Device (Doctormate®) inflating tourniquets to 60mmHg.</description>
    <arm_group_label>Doctormate® (60mmHg)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female with age from 40 to 80 years old.

          2. Patients having an ischemic stroke or a TIA prior to randomization.

               -  Patient having an ischemic stroke within 30 days with mRS score≤4 at baseline.

               -  Patient having a TIA within 15 days with Oxfordshire Community Stroke Project on
                  the basis of age, blood pressure (BP), clinical features, and duration of TIA
                  symptoms (ABCD2) score≥4 at baseline.

          3. The entry event is attributed to symptomatic atherosclerotic stenosis (50-99%) in an
             intracranial qualifying artery (carotid artery, middle cerebral artery (M1), vertebral
             artery, or basilar artery) that is documented by magnetic resonance angiography (MRA)
             or computed tomographic angiography (CTA).

          4. Informed consent obtained.

        Exclusion Criteria:

          1. Thrombolytic therapy within 24 hours prior to enrollment.

          2. Progressive neurological signs within 24 hours prior to enrollment.

          3. Cerebral venous thrombosis/stenosis.

          4. Intracranial arterial stenosis due to arterial dissection, Moya Moya disease; any
             known vasculitic disease; herpes zoster, varicella zoster or other viral vasculopathy;
             neurosyphilis; any other intracranial infection; any intracranial stenosis associated
             with cerebrospinal fluid (CSF) pleocytosis; radiation induced vasculopathy;
             fibromuscular dysplasia; sickle cell disease; neurofibromatosis; benign angiopathy of
             central nervous system; post-partum angiopathy; suspected vasospastic process,
             suspected recanalized embolus.

          5. Any of the following unequivocal cardiac source of embolism: rheumatic mitral and or
             aortic stenosis, prosthetic heart valves, atrial fibrillation, atrial flutter, sick
             sinus syndrome, left atrial myxoma, patent foramen ovale, left ventricular mural
             thrombus or valvular vegetation, congestive heart failure, bacterial endocarditis, or
             any other cardiovascular condition interfering with the participation.

          6. Uncontrolled severe hypertension [sitting systolic blood pressure (SBP) &gt;180 mmHg
             and/or sitting diastolic blood pressure (DBP) &gt;110 mmHg after medication].

          7. Patients with abnormal laboratory parameters: aspartate transaminase (AST) and/or
             alanine transaminase (ALT) &gt;3×upper limit of normal range; creatinine clearance &lt;0.6
             ml/s and/or serum creatinine &gt;265 μmol/l (&gt;3.0 mg/dl); platelets &lt;100×109/L.

          8. Any intracranial hemorrhage (parenchymal, subarachnoid, subdural, epidural) within 90
             days prior to enrollment.

          9. Intracranial neoplasm, cerebral aneurysm or arteriovenous malformation.

         10. Known retinal hemorrhage or visceral bleeding within 30 days prior to enrollment.

         11. Severe hemostatic disorder or severe coagulation dysfunction.

         12. Subclavian arterial stenosis≥50% or subclavian steal syndrome.

         13. Extracranial stenosis ≥50%.

         14. Previous treatment of target lesion with a stent, angioplasty, or other mechanical
             device, or plan to perform one of these procedures within 12 months after enrollment.

         15. Major surgery (including open femoral, aortic, or carotid surgery, cardiac) within
             previous 30 days or scheduled in the 12 months after enrollment.

         16. Contraindication for remote ischemic conditioning: severe soft tissue injury,
             fracture, or peripheral vascular disease in the upper limbs.

         17. Life expectancy&lt;3 years.

         18. Pregnant or breast-feeding women.

         19. Unwilling to be followed up or poor compliance for treatment.

         20. Patients being enrolled or having been enrolled in other clinical trial within 3
             months prior to this clinical trial.

         21. Patients unsuitable for enrollment in the clinical trial according to investigators
             decision making.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xunming Ji, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xuanwu Hospital, Beijing</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xunming Ji, MD. PhD</last_name>
    <phone>+86-10-83198952</phone>
    <email>jixunming@vip.163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wuhu NO.2 People's Hospital</name>
      <address>
        <city>Wuhu</city>
        <state>Anhui</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongbo Pang</last_name>
    </contact>
    <investigator>
      <last_name>Hongbo Pang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Hospital of Shunyi District Beijing</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>101300</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Quping Ouyang</last_name>
    </contact>
    <investigator>
      <last_name>Quping Ouyang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Huairou Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fuying Yu</last_name>
    </contact>
    <investigator>
      <last_name>Fuying Yu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baoding No.1 Hospital</name>
      <address>
        <city>Baoding</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chunsheng Wang</last_name>
    </contact>
    <investigator>
      <last_name>Chunsheng Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cangzhou People Hospital</name>
      <address>
        <city>Cangzhou</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jie Huang</last_name>
    </contact>
    <investigator>
      <last_name>Jie Huang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hebei Province Cangzhou Hospital of Integrated Traditional and Western Medicine</name>
      <address>
        <city>Cangzhou</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhiyong Wang</last_name>
    </contact>
    <investigator>
      <last_name>Zhiyong Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chengde Central Hospital</name>
      <address>
        <city>Chengde</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haisong Du</last_name>
    </contact>
    <investigator>
      <last_name>Haisong Du</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Handan First Hospital</name>
      <address>
        <city>Handan</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liping Cheng</last_name>
    </contact>
    <investigator>
      <last_name>Liping Cheng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hebei General Hospital</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peiyuan Lu</last_name>
    </contact>
    <investigator>
      <last_name>Peiyuan Lu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shijiazhuang The First Hospital</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhenquan Yan</last_name>
    </contact>
    <investigator>
      <last_name>Zhenquan Yan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shijiazhuang The Third Hospital</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunshu Zhang</last_name>
    </contact>
    <investigator>
      <last_name>Yunshu Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xueqin Song</last_name>
    </contact>
    <investigator>
      <last_name>Xueqin Song</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third Houspital of Xingtai</name>
      <address>
        <city>Xingtai</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuqing Wei</last_name>
    </contact>
    <investigator>
      <last_name>Yuqing Wei</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xingtai People's Hospital</name>
      <address>
        <city>Xingtai</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peilin Hu</last_name>
    </contact>
    <investigator>
      <last_name>Peilin Hu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Clinical Hospital affiliated to Harbin Medical University</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guozhong Li</last_name>
    </contact>
    <investigator>
      <last_name>Guozhong Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Fourth Hospital of Harbin Medical University</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhuobo Zhang</last_name>
    </contact>
    <investigator>
      <last_name>Zhuobo Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Luohe Central Hospital</name>
      <address>
        <city>Luohe</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chunling Zheng</last_name>
    </contact>
    <investigator>
      <last_name>Chunling Zheng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shangqiu First People's Hospital</name>
      <address>
        <city>Shangqiu</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yan Fang</last_name>
    </contact>
    <investigator>
      <last_name>Yan Fang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xuchang Central Hospital</name>
      <address>
        <city>Xuchang</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tao Li</last_name>
    </contact>
    <investigator>
      <last_name>Tao Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhumadian Ctentral Hospital</name>
      <address>
        <city>Zhumadian</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xuezhang Lai</last_name>
    </contact>
    <investigator>
      <last_name>Xuezhang Lai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Technology The Central Hospital of Wuhan</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linhong Zhang</last_name>
    </contact>
    <investigator>
      <last_name>Linhong Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inner Mongolia People's Hospital</name>
      <address>
        <city>Hohhot</city>
        <state>Inner Mongolia</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Runxiu Zhu</last_name>
    </contact>
    <investigator>
      <last_name>Runxiu Zhu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Changzhou NO.2 People's Hospital</name>
      <address>
        <city>Changzhou</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhuoyou Chen</last_name>
    </contact>
    <investigator>
      <last_name>Zhuoyou Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Anshanshi Changda The Hospital</name>
      <address>
        <city>Anshan</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiujie Han</last_name>
    </contact>
    <investigator>
      <last_name>Xiujie Han</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chaoyang Central Hospital</name>
      <address>
        <city>Chaoyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaomei He</last_name>
    </contact>
    <investigator>
      <last_name>Xiaomei He</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dalian Municipal Central Hospital Affiliated of Dalian Medical University</name>
      <address>
        <city>Dalian</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Wang</last_name>
    </contact>
    <investigator>
      <last_name>Hong Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jinzhou Central Hopital</name>
      <address>
        <city>Jinzhou</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dongyu Wang</last_name>
    </contact>
    <investigator>
      <last_name>Dongyu Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third Affiliated Hospital of Liaoning Medical College</name>
      <address>
        <city>Jinzhou</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hui Zhang</last_name>
    </contact>
    <investigator>
      <last_name>Hui Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Shenyang</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin Zhou</last_name>
    </contact>
    <investigator>
      <last_name>Jin Zhou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The General Hospital of Shenyang Military</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Huisheng Chen</last_name>
    </contact>
    <investigator>
      <last_name>Huisheng Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Peoele's Hospital of Liaoning Province</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaohong Chen</last_name>
    </contact>
    <investigator>
      <last_name>Xiaohong Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ankang City Central Hospital</name>
      <address>
        <city>Ankang</city>
        <state>Shaanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaifu Jiang</last_name>
    </contact>
    <investigator>
      <last_name>Kaifu Jiang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dezhou People's Hospital</name>
      <address>
        <city>Dezhou</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaohua Su</last_name>
    </contact>
    <investigator>
      <last_name>Shaohua Su</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shengli Oilfield Central Hospital</name>
      <address>
        <city>Dongying</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zongen Gao</last_name>
    </contact>
    <investigator>
      <last_name>Zongen Gao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Linyi People's Hospital</name>
      <address>
        <city>Linyi</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongxing Han</last_name>
    </contact>
    <investigator>
      <last_name>Hongxing Han</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rizhao Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Rizhao</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Ding</last_name>
    </contact>
    <investigator>
      <last_name>Wei Ding</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Weifang Medical University</name>
      <address>
        <city>Weifang</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xianwei Zeng</last_name>
    </contact>
    <investigator>
      <last_name>Xianwei Zeng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peace Hospital Affiliated to Changzhi Medical College Shanxi Province</name>
      <address>
        <city>Changzhi</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yufen Wang</last_name>
    </contact>
    <investigator>
      <last_name>Yufen Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fenyang Hospital of Shanxi Medical Unversity</name>
      <address>
        <city>Fenyang</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xueying Guo</last_name>
    </contact>
    <investigator>
      <last_name>Xueying Guo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>First Hospital of Shanxi Medical Unversity</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoyuan Niu</last_name>
    </contact>
    <investigator>
      <last_name>Xiaoyuan Niu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanxi College of Traditional Chinese Medicine Hospital</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aimei Wang</last_name>
    </contact>
    <investigator>
      <last_name>Aimei Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tianjin 4th Centre Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongxin Wang</last_name>
    </contact>
    <investigator>
      <last_name>Hongxin Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tianjin Huanhu Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Yue</last_name>
    </contact>
    <investigator>
      <last_name>Wei Yue</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tianjin Medical University General Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Junwei Hao</last_name>
    </contact>
    <investigator>
      <last_name>Junwei Hao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shaoxing Central Hospital</name>
      <address>
        <city>Shaoxing</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ke Shen</last_name>
    </contact>
    <investigator>
      <last_name>Ke Shen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhoushan Putuo Hospital</name>
      <address>
        <city>Zhoushan</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ming Wang</last_name>
    </contact>
    <investigator>
      <last_name>Ming Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xuanwu Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <zip>100053</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xunming Ji</last_name>
    </contact>
    <investigator>
      <last_name>Xunming Ji</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Aerospace General Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jilai Li</last_name>
    </contact>
    <investigator>
      <last_name>Jilai Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Luhe Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huishan Du</last_name>
    </contact>
    <investigator>
      <last_name>Huishan Du</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xiyuan Hospital, China Academy of Chinses Medical Sciences</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chenguang Tong</last_name>
    </contact>
    <investigator>
      <last_name>Chenguang Tong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2015</study_first_submitted>
  <study_first_submitted_qc>August 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2015</study_first_posted>
  <last_update_submitted>May 23, 2018</last_update_submitted>
  <last_update_submitted_qc>May 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Capital Medical University</investigator_affiliation>
    <investigator_full_name>Ji Xunming,MD,PhD</investigator_full_name>
    <investigator_title>VP, Professor</investigator_title>
  </responsible_party>
  <keyword>Intracranial atherosclerotic stenosis</keyword>
  <keyword>ischemia</keyword>
  <keyword>remote ischemic conditioning</keyword>
  <keyword>stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Intracranial Arteriosclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

